Rank | Gene Set | Z-score |
---|---|---|
1 | low-density lipoprotein particle clearance (GO:0034383) | 4.56833097 |
2 | polyketide metabolic process (GO:0030638) | 4.05016038 |
3 | doxorubicin metabolic process (GO:0044598) | 4.05016038 |
4 | daunorubicin metabolic process (GO:0044597) | 4.05016038 |
5 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.79446585 |
6 | barbed-end actin filament capping (GO:0051016) | 3.67647278 |
7 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.49345231 |
8 | positive regulation of p38MAPK cascade (GO:1900745) | 3.49199330 |
9 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.48292505 |
10 | glycolipid catabolic process (GO:0019377) | 3.48146901 |
11 | glycosphingolipid catabolic process (GO:0046479) | 3.45470056 |
12 | positive regulation of extracellular matrix organization (GO:1903055) | 3.43769112 |
13 | skin morphogenesis (GO:0043589) | 3.34759134 |
14 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.29923957 |
15 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.29009185 |
16 | protein retention in ER lumen (GO:0006621) | 3.21808476 |
17 | growth hormone receptor signaling pathway (GO:0060396) | 3.16409054 |
18 | oligosaccharide catabolic process (GO:0009313) | 3.16303573 |
19 | positive regulation of heat generation (GO:0031652) | 3.13236571 |
20 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.08956455 |
21 | modulation by symbiont of host immune response (GO:0052553) | 3.08956455 |
22 | positive regulation by symbiont of host defense response (GO:0052509) | 3.08956455 |
23 | modulation by symbiont of host defense response (GO:0052031) | 3.08956455 |
24 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.08956455 |
25 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.08956455 |
26 | hyaluronan catabolic process (GO:0030214) | 2.98985092 |
27 | neutrophil activation involved in immune response (GO:0002283) | 2.89261577 |
28 | apoptotic cell clearance (GO:0043277) | 2.89160110 |
29 | regulation of cholesterol storage (GO:0010885) | 2.89061672 |
30 | glycoside metabolic process (GO:0016137) | 2.88285650 |
31 | pinocytosis (GO:0006907) | 2.86396224 |
32 | cell adhesion mediated by integrin (GO:0033627) | 2.86257392 |
33 | pentose-phosphate shunt (GO:0006098) | 2.83486133 |
34 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.81985745 |
35 | cellular response to growth hormone stimulus (GO:0071378) | 2.81044392 |
36 | response to thyroid hormone (GO:0097066) | 2.80620405 |
37 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.80406284 |
38 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.79608869 |
39 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.78383634 |
40 | epithelial cell-cell adhesion (GO:0090136) | 2.77626878 |
41 | regulation of early endosome to late endosome transport (GO:2000641) | 2.77257188 |
42 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.76923877 |
43 | regulation of podosome assembly (GO:0071801) | 2.75403340 |
44 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.74794219 |
45 | positive regulation of receptor recycling (GO:0001921) | 2.73971238 |
46 | regulation of fever generation (GO:0031620) | 2.73070383 |
47 | protein localization to endosome (GO:0036010) | 2.72078995 |
48 | basement membrane organization (GO:0071711) | 2.69931503 |
49 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.69922371 |
50 | cyclooxygenase pathway (GO:0019371) | 2.68954016 |
51 | macrophage activation involved in immune response (GO:0002281) | 2.67131068 |
52 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.66257456 |
53 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.66025434 |
54 | regulation of p38MAPK cascade (GO:1900744) | 2.65421781 |
55 | response to muramyl dipeptide (GO:0032495) | 2.65069021 |
56 | ceramide catabolic process (GO:0046514) | 2.63802399 |
57 | adhesion of symbiont to host (GO:0044406) | 2.60633804 |
58 | protein hydroxylation (GO:0018126) | 2.59415127 |
59 | membrane lipid catabolic process (GO:0046466) | 2.58054069 |
60 | plasma lipoprotein particle clearance (GO:0034381) | 2.57465339 |
61 | fibrinolysis (GO:0042730) | 2.56696838 |
62 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.53725902 |
63 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.53387742 |
64 | amino sugar catabolic process (GO:0046348) | 2.52905801 |
65 | response to peptidoglycan (GO:0032494) | 2.52072208 |
66 | progesterone metabolic process (GO:0042448) | 2.49677496 |
67 | cell-substrate junction assembly (GO:0007044) | 2.48171231 |
68 | glucose 6-phosphate metabolic process (GO:0051156) | 2.47172582 |
69 | negative regulation of fibrinolysis (GO:0051918) | 2.47099818 |
70 | positive regulation of macrophage cytokine production (GO:0060907) | 2.45964868 |
71 | mannose metabolic process (GO:0006013) | 2.45884584 |
72 | NADPH regeneration (GO:0006740) | 2.45018868 |
73 | regulation of chemokine biosynthetic process (GO:0045073) | 2.44229241 |
74 | response to laminar fluid shear stress (GO:0034616) | 2.44164941 |
75 | COPI coating of Golgi vesicle (GO:0048205) | 2.43925874 |
76 | Golgi transport vesicle coating (GO:0048200) | 2.43925874 |
77 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.43157938 |
78 | peptidyl-proline hydroxylation (GO:0019511) | 2.43014701 |
79 | glucose catabolic process (GO:0006007) | 2.41837140 |
80 | hemidesmosome assembly (GO:0031581) | 2.40972519 |
81 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.40681614 |
82 | positive regulation of lipid storage (GO:0010884) | 2.39710955 |
83 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.39232406 |
84 | endodermal cell differentiation (GO:0035987) | 2.37754363 |
85 | regulation of vitamin metabolic process (GO:0030656) | 2.37553645 |
86 | decidualization (GO:0046697) | 2.36865428 |
87 | response to manganese ion (GO:0010042) | 2.36848960 |
88 | regulation of extracellular matrix organization (GO:1903053) | 2.35358496 |
89 | membrane protein ectodomain proteolysis (GO:0006509) | 2.35009686 |
90 | * macroautophagy (GO:0016236) | 2.34710240 |
91 | regulation of heat generation (GO:0031650) | 2.34680575 |
92 | negative regulation of lipid storage (GO:0010888) | 2.34679258 |
93 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.34486820 |
94 | primary alcohol catabolic process (GO:0034310) | 2.34232363 |
95 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.33972411 |
96 | sexual reproduction (GO:0019953) | 2.33951807 |
97 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.33862758 |
98 | regulation of cholesterol homeostasis (GO:2000188) | 2.32574453 |
99 | sphingolipid catabolic process (GO:0030149) | 2.32033376 |
100 | embryo implantation (GO:0007566) | 2.29599453 |
101 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.29509452 |
102 | response to arsenic-containing substance (GO:0046685) | 2.29366517 |
103 | regulation of extracellular matrix disassembly (GO:0010715) | 2.28902773 |
104 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.28829627 |
105 | membrane raft organization (GO:0031579) | 2.28389549 |
106 | hypotonic response (GO:0006971) | 2.27970201 |
107 | keratan sulfate catabolic process (GO:0042340) | 2.25863166 |
108 | glial cell migration (GO:0008347) | 2.25284534 |
109 | regulation of mononuclear cell migration (GO:0071675) | 2.24448270 |
110 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.24300986 |
111 | focal adhesion assembly (GO:0048041) | 2.23735472 |
112 | cell-substrate adherens junction assembly (GO:0007045) | 2.23735472 |
113 | amyloid precursor protein catabolic process (GO:0042987) | 2.22255239 |
114 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.22183581 |
115 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.21946681 |
116 | endocytic recycling (GO:0032456) | 2.21803108 |
117 | adherens junction assembly (GO:0034333) | 2.21693296 |
118 | cellular copper ion homeostasis (GO:0006878) | 2.21498802 |
119 | phagosome maturation (GO:0090382) | 2.20583166 |
120 | NIK/NF-kappaB signaling (GO:0038061) | 2.20573184 |
121 | peptide catabolic process (GO:0043171) | 2.20409815 |
122 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.20407092 |
123 | substrate-dependent cell migration (GO:0006929) | 2.20241811 |
124 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.19616516 |
125 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.19499809 |
126 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.19497295 |
127 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.19490261 |
128 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.19490261 |
129 | activation of MAPKKK activity (GO:0000185) | 2.19161872 |
130 | endothelial cell chemotaxis (GO:0035767) | 2.18345344 |
131 | cellular response to nicotine (GO:0071316) | 2.17620055 |
132 | positive regulation of interferon-alpha production (GO:0032727) | 2.17196428 |
133 | nitric oxide biosynthetic process (GO:0006809) | 2.17094611 |
134 | granulocyte activation (GO:0036230) | 2.14399576 |
135 | wound healing, spreading of epidermal cells (GO:0035313) | 2.14150946 |
136 | regulation of interferon-alpha production (GO:0032647) | 2.13570538 |
137 | positive regulation of nuclease activity (GO:0032075) | 2.13199286 |
138 | cellular response to unfolded protein (GO:0034620) | 2.12348171 |
139 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.11639058 |
140 | regulation of macrophage cytokine production (GO:0010935) | 2.10241353 |
141 | cerebellar Purkinje cell layer development (GO:0021680) | 2.10228550 |
142 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.07690400 |
143 | T-helper 1 type immune response (GO:0042088) | 2.07236672 |
144 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.06779223 |
145 | negative regulation of interleukin-17 production (GO:0032700) | 2.06597952 |
146 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.05017517 |
147 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.05000481 |
148 | respiratory burst (GO:0045730) | 2.04504930 |
149 | ER-nucleus signaling pathway (GO:0006984) | 2.04271094 |
150 | plasma membrane repair (GO:0001778) | 2.03712049 |
151 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.03669674 |
152 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.02161604 |
153 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.02130518 |
154 | virion attachment to host cell (GO:0019062) | 2.02042370 |
155 | adhesion of symbiont to host cell (GO:0044650) | 2.02042370 |
156 | natural killer cell mediated immunity (GO:0002228) | 2.01918052 |
157 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.01918052 |
158 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.01839094 |
159 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.01476751 |
160 | reactive oxygen species biosynthetic process (GO:1903409) | 2.00812438 |
161 | regulation of lipid storage (GO:0010883) | 2.00485165 |
162 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 1.98872706 |
163 | response to host immune response (GO:0052572) | 1.98872706 |
164 | positive regulation of leukocyte degranulation (GO:0043302) | 1.98669854 |
165 | regulation of integrin activation (GO:0033623) | 1.98523176 |
166 | myeloid cell homeostasis (GO:0002262) | 1.97926385 |
167 | cellular response to arsenic-containing substance (GO:0071243) | 1.97808979 |
168 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 1.97497560 |
169 | stress fiber assembly (GO:0043149) | 1.97199785 |
170 | cellular response to cadmium ion (GO:0071276) | 1.96385169 |
171 | detection of molecule of bacterial origin (GO:0032490) | 1.94785503 |
172 | cellular response to topologically incorrect protein (GO:0035967) | 1.94772631 |
173 | response to growth hormone (GO:0060416) | 1.94309767 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.14988481 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.83049166 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.66080662 |
4 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.62915609 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.53858676 |
6 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.51106654 |
7 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.50892338 |
8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.36636877 |
9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.25104999 |
10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.23944559 |
11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.21500212 |
12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15610898 |
13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.14058737 |
14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06771329 |
15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.04571365 |
16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.01178499 |
17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.00477612 |
18 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.99653790 |
19 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.98839086 |
20 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.94436037 |
21 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.93873717 |
22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.90467126 |
23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.85967303 |
24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.85049617 |
25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.74377589 |
26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.74321623 |
27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.73553782 |
28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71050473 |
29 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.70942147 |
30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.70255937 |
31 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.69445908 |
32 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69082070 |
33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.67744791 |
34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.60635252 |
35 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.55325216 |
36 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.54341809 |
37 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48186709 |
38 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.47372968 |
39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.45615400 |
40 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.40978855 |
41 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40788387 |
42 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38519431 |
43 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38519431 |
44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36860253 |
45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.33716906 |
46 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.33557300 |
47 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.32354153 |
48 | KDM2B_26808549_Chip-Seq_K562_Human | 1.28867933 |
49 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28795377 |
50 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.28414828 |
51 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27866290 |
52 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.27773752 |
53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27596264 |
54 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.27249158 |
55 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.26453264 |
56 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.26100189 |
57 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.25564471 |
58 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21487269 |
59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.20607382 |
60 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.18895363 |
61 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.18768970 |
62 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18580525 |
63 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.17730118 |
64 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.17665121 |
65 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16967628 |
66 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.16002783 |
67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15552209 |
68 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15198125 |
69 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14857296 |
70 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14771316 |
71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14679602 |
72 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14464422 |
73 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14373498 |
74 | MYC_22102868_ChIP-Seq_BL_Human | 1.13404595 |
75 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.12727286 |
76 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11740589 |
77 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11733266 |
78 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.11440080 |
79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11297982 |
80 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11059915 |
81 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.10970383 |
82 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.10689519 |
83 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09663866 |
84 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09521100 |
85 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09223631 |
86 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09056960 |
87 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09000886 |
88 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.08699209 |
89 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08545030 |
90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.08370163 |
91 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07326642 |
92 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.05921654 |
93 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.05713300 |
94 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04253725 |
95 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04123808 |
96 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03199050 |
97 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01956336 |
98 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.01587728 |
99 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01092017 |
100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00770029 |
101 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00685767 |
102 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.00034505 |
103 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.97444637 |
104 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97386930 |
105 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97131885 |
106 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96780910 |
107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96265668 |
108 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96181124 |
109 | * MAF_26560356_Chip-Seq_TH1_Human | 0.95962191 |
110 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.95676719 |
111 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95256063 |
112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95024873 |
113 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94989062 |
114 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.94815720 |
115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94807516 |
116 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.92524948 |
117 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.92335141 |
118 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91366154 |
119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91150713 |
120 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90996652 |
121 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.90000167 |
122 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.89380223 |
123 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88675574 |
124 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.88562807 |
125 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.88562807 |
126 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88504385 |
127 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.87669467 |
128 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87619261 |
129 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87577780 |
130 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.87560801 |
131 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.87309936 |
132 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.87309936 |
133 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.86954022 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 3.51400957 |
2 | MP0005451_abnormal_body_composition | 3.09427752 |
3 | MP0005058_abnormal_lysosome_morphology | 3.02154720 |
4 | MP0004510_myositis | 2.92491509 |
5 | MP0009840_abnormal_foam_cell | 2.52109616 |
6 | MP0003172_abnormal_lysosome_physiology | 2.42030036 |
7 | MP0003436_decreased_susceptibility_to | 2.37993646 |
8 | MP0004858_abnormal_nervous_system | 2.35412904 |
9 | MP0003195_calcinosis | 2.29337862 |
10 | MP0003300_gastrointestinal_ulcer | 2.22005083 |
11 | MP0000604_amyloidosis | 2.14838183 |
12 | MP0009785_altered_susceptibility_to | 2.09629004 |
13 | MP0003705_abnormal_hypodermis_morpholog | 2.08366840 |
14 | MP0002877_abnormal_melanocyte_morpholog | 2.08059569 |
15 | MP0002138_abnormal_hepatobiliary_system | 2.03612284 |
16 | MP0003075_altered_response_to | 1.98266910 |
17 | MP0008260_abnormal_autophagy | 1.94563458 |
18 | MP0004947_skin_inflammation | 1.84684322 |
19 | MP0004272_abnormal_basement_membrane | 1.82612901 |
20 | MP0005167_abnormal_blood-brain_barrier | 1.74232256 |
21 | MP0008438_abnormal_cutaneous_collagen | 1.72920955 |
22 | MP0006082_CNS_inflammation | 1.70149613 |
23 | MP0003566_abnormal_cell_adhesion | 1.67119382 |
24 | MP0003329_amyloid_beta_deposits | 1.66859024 |
25 | * MP0002419_abnormal_innate_immunity | 1.64703227 |
26 | MP0003091_abnormal_cell_migration | 1.64172401 |
27 | MP0003191_abnormal_cellular_cholesterol | 1.60527227 |
28 | MP0003279_aneurysm | 1.59242826 |
29 | MP0005000_abnormal_immune_tolerance | 1.58238469 |
30 | MP0001533_abnormal_skeleton_physiology | 1.56897365 |
31 | MP0004233_abnormal_muscle_weight | 1.56439103 |
32 | MP0002139_abnormal_hepatobiliary_system | 1.55051387 |
33 | MP0003724_increased_susceptibility_to | 1.52694262 |
34 | MP0009764_decreased_sensitivity_to | 1.52609911 |
35 | MP0002909_abnormal_adrenal_gland | 1.51299531 |
36 | MP0000343_altered_response_to | 1.51284547 |
37 | MP0005083_abnormal_biliary_tract | 1.47242273 |
38 | MP0002148_abnormal_hypersensitivity_rea | 1.47105470 |
39 | MP0003950_abnormal_plasma_membrane | 1.47065093 |
40 | MP0001849_ear_inflammation | 1.39954640 |
41 | MP0005076_abnormal_cell_differentiation | 1.39681658 |
42 | MP0009278_abnormal_bone_marrow | 1.37586455 |
43 | MP0008961_abnormal_basal_metabolism | 1.36601380 |
44 | MP0000685_abnormal_immune_system | 1.36349994 |
45 | MP0003453_abnormal_keratinocyte_physiol | 1.36159958 |
46 | MP0003448_altered_tumor_morphology | 1.35937627 |
47 | MP0004130_abnormal_muscle_cell | 1.34796160 |
48 | MP0005387_immune_system_phenotype | 1.31425834 |
49 | MP0001790_abnormal_immune_system | 1.31425834 |
50 | MP0005464_abnormal_platelet_physiology | 1.31213050 |
51 | MP0005025_abnormal_response_to | 1.30779332 |
52 | MP0003183_abnormal_peptide_metabolism | 1.29711551 |
53 | MP0001835_abnormal_antigen_presentation | 1.28663076 |
54 | MP0000751_myopathy | 1.28345445 |
55 | * MP0002998_abnormal_bone_remodeling | 1.26424326 |
56 | MP0005164_abnormal_response_to | 1.21675961 |
57 | MP0001845_abnormal_inflammatory_respons | 1.20622008 |
58 | MP0005166_decreased_susceptibility_to | 1.18460235 |
59 | MP0003045_fibrosis | 1.18260816 |
60 | MP0002060_abnormal_skin_morphology | 1.17591169 |
61 | MP0001958_emphysema | 1.17082330 |
62 | MP0003806_abnormal_nucleotide_metabolis | 1.15766564 |
63 | MP0008469_abnormal_protein_level | 1.15465127 |
64 | MP0000013_abnormal_adipose_tissue | 1.15163265 |
65 | MP0003828_pulmonary_edema | 1.13484611 |
66 | MP0001542_abnormal_bone_strength | 1.11675443 |
67 | MP0005257_abnormal_intraocular_pressure | 1.10894785 |
68 | MP0010234_abnormal_vibrissa_follicle | 1.09679481 |
69 | MP0003656_abnormal_erythrocyte_physiolo | 1.07913478 |
70 | MP0003690_abnormal_glial_cell | 1.07712184 |
71 | MP0002254_reproductive_system_inflammat | 1.07627276 |
72 | MP0005023_abnormal_wound_healing | 1.07185780 |
73 | MP0002896_abnormal_bone_mineralization | 1.06315558 |
74 | MP0000609_abnormal_liver_physiology | 1.04148415 |
75 | MP0005275_abnormal_skin_tensile | 1.02385106 |
76 | * MP0002723_abnormal_immune_serum | 1.00320824 |
77 | MP0005360_urolithiasis | 0.99519793 |
78 | * MP0002452_abnormal_antigen_presenting | 0.98186410 |
79 | MP0005319_abnormal_enzyme/_coenzyme | 0.95675796 |
80 | MP0010352_gastrointestinal_tract_polyps | 0.95451858 |
81 | MP0000733_abnormal_muscle_development | 0.95375057 |
82 | MP0002332_abnormal_exercise_endurance | 0.95281808 |
83 | MP0006054_spinal_hemorrhage | 0.94200760 |
84 | MP0000858_altered_metastatic_potential | 0.93655663 |
85 | MP0004185_abnormal_adipocyte_glucose | 0.93583775 |
86 | MP0000750_abnormal_muscle_regeneration | 0.93110042 |
87 | MP0003186_abnormal_redox_activity | 0.93035065 |
88 | MP0001853_heart_inflammation | 0.91618319 |
89 | MP0003252_abnormal_bile_duct | 0.91072922 |
90 | MP0002090_abnormal_vision | 0.90904960 |
91 | MP0005623_abnormal_meninges_morphology | 0.90901501 |
92 | MP0002405_respiratory_system_inflammati | 0.89747146 |
93 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89056473 |
94 | MP0003221_abnormal_cardiomyocyte_apopto | 0.88885046 |
95 | MP0002118_abnormal_lipid_homeostasis | 0.88288002 |
96 | MP0009333_abnormal_splenocyte_physiolog | 0.88261198 |
97 | MP0000767_abnormal_smooth_muscle | 0.88212571 |
98 | MP0005535_abnormal_body_temperature | 0.87769720 |
99 | MP0000003_abnormal_adipose_tissue | 0.87024602 |
100 | MP0010386_abnormal_urinary_bladder | 0.85436578 |
101 | MP0009643_abnormal_urine_homeostasis | 0.85247765 |
102 | MP0003634_abnormal_glial_cell | 0.85059865 |
103 | MP0005365_abnormal_bile_salt | 0.84932997 |
104 | MP0010329_abnormal_lipoprotein_level | 0.84609856 |
105 | MP0001915_intracranial_hemorrhage | 0.84566765 |
106 | MP0000747_muscle_weakness | 0.84399941 |
107 | MP0000249_abnormal_blood_vessel | 0.83960154 |
108 | MP0001348_abnormal_lacrimal_gland | 0.83939005 |
109 | MP0005390_skeleton_phenotype | 0.83316482 |
110 | MP0005595_abnormal_vascular_smooth | 0.82691071 |
111 | MP0008875_abnormal_xenobiotic_pharmacok | 0.82484544 |
112 | MP0001501_abnormal_sleep_pattern | 0.82456930 |
113 | MP0001243_abnormal_dermal_layer | 0.82367088 |
114 | MP0002796_impaired_skin_barrier | 0.81789086 |
115 | MP0005332_abnormal_amino_acid | 0.81678366 |
116 | MP0010155_abnormal_intestine_physiology | 0.81111366 |
117 | MP0005666_abnormal_adipose_tissue | 0.80645588 |
118 | MP0005165_increased_susceptibility_to | 0.79752552 |
119 | MP0008874_decreased_physiological_sensi | 0.79509919 |
120 | MP0002168_other_aberrant_phenotype | 0.79381365 |
121 | MP0000759_abnormal_skeletal_muscle | 0.78815306 |
122 | MP0003283_abnormal_digestive_organ | 0.78445681 |
123 | * MP0002078_abnormal_glucose_homeostasis | 0.78274048 |
124 | MP0002693_abnormal_pancreas_physiology | 0.77452778 |
125 | MP0002295_abnormal_pulmonary_circulatio | 0.77305565 |
126 | MP0000371_diluted_coat_color | 0.75638870 |
127 | MP0000749_muscle_degeneration | 0.75505320 |
128 | MP0005375_adipose_tissue_phenotype | 0.74922727 |
129 | MP0002837_dystrophic_cardiac_calcinosis | 0.74265462 |
130 | MP0001216_abnormal_epidermal_layer | 0.74090680 |
131 | MP0003868_abnormal_feces_composition | 0.73585920 |
132 | MP0005330_cardiomyopathy | 0.73485622 |
133 | MP0005310_abnormal_salivary_gland | 0.73098247 |
134 | MP0005621_abnormal_cell_physiology | 0.72576461 |
135 | MP0000920_abnormal_myelination | 0.71952444 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Increased cerebral lipofuscin (HP:0011813) | 3.96207411 |
2 | Eczematoid dermatitis (HP:0000976) | 3.72753690 |
3 | Dysostosis multiplex (HP:0000943) | 3.64112841 |
4 | * Vertebral compression fractures (HP:0002953) | 3.42930228 |
5 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.39114130 |
6 | Mucopolysacchariduria (HP:0008155) | 3.39114130 |
7 | Axonal loss (HP:0003447) | 3.37186111 |
8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.32361744 |
9 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.26440505 |
10 | Nuclear cataract (HP:0100018) | 3.24848525 |
11 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.21574869 |
12 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.21574869 |
13 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.21574869 |
14 | Distal lower limb muscle weakness (HP:0009053) | 3.10682509 |
15 | Myocardial infarction (HP:0001658) | 3.07659047 |
16 | Abnormality of macrophages (HP:0004311) | 3.03540839 |
17 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.87580657 |
18 | Vacuolated lymphocytes (HP:0001922) | 2.86013879 |
19 | Interstitial pulmonary disease (HP:0006530) | 2.76026533 |
20 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.75491900 |
21 | Osteolytic defects of the hand bones (HP:0009699) | 2.75491900 |
22 | Stomatitis (HP:0010280) | 2.74278328 |
23 | Distal upper limb amyotrophy (HP:0007149) | 2.71800144 |
24 | Upper limb amyotrophy (HP:0009129) | 2.71800144 |
25 | Asymmetric septal hypertrophy (HP:0001670) | 2.70529041 |
26 | Abnormality of glycolipid metabolism (HP:0010969) | 2.69472112 |
27 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.69472112 |
28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.69472112 |
29 | Recurrent abscess formation (HP:0002722) | 2.68429467 |
30 | Amyloidosis (HP:0011034) | 2.59155068 |
31 | Abnormality of complement system (HP:0005339) | 2.59130709 |
32 | Recurrent bacterial skin infections (HP:0005406) | 2.57892772 |
33 | Short nail (HP:0001799) | 2.55255086 |
34 | Orchitis (HP:0100796) | 2.50522045 |
35 | Supranuclear gaze palsy (HP:0000605) | 2.50352167 |
36 | Cerebral aneurysm (HP:0004944) | 2.43475434 |
37 | Hand muscle atrophy (HP:0009130) | 2.42000798 |
38 | Loss of speech (HP:0002371) | 2.40645330 |
39 | Peritonitis (HP:0002586) | 2.40434556 |
40 | Spinal rigidity (HP:0003306) | 2.37290424 |
41 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.36319549 |
42 | Hypercortisolism (HP:0001578) | 2.32814851 |
43 | Complement deficiency (HP:0004431) | 2.31511103 |
44 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.28605653 |
45 | Vascular tortuosity (HP:0004948) | 2.28445803 |
46 | Hyperacusis (HP:0010780) | 2.28303069 |
47 | Prolonged neonatal jaundice (HP:0006579) | 2.27327720 |
48 | Xanthomatosis (HP:0000991) | 2.27067040 |
49 | Neurofibrillary tangles (HP:0002185) | 2.23956020 |
50 | Arterial tortuosity (HP:0005116) | 2.23216572 |
51 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.22455578 |
52 | Global brain atrophy (HP:0002283) | 2.22094193 |
53 | J-shaped sella turcica (HP:0002680) | 2.21576662 |
54 | Ankle contracture (HP:0006466) | 2.20042191 |
55 | Frequent falls (HP:0002359) | 2.17865815 |
56 | Abnormality of the Achilles tendon (HP:0005109) | 2.16791207 |
57 | Achilles tendon contracture (HP:0001771) | 2.15791966 |
58 | Gingivitis (HP:0000230) | 2.14403659 |
59 | Retrobulbar optic neuritis (HP:0100654) | 2.12647807 |
60 | Optic neuritis (HP:0100653) | 2.12647807 |
61 | Cerebral inclusion bodies (HP:0100314) | 2.12593332 |
62 | Atrophic scars (HP:0001075) | 2.12303125 |
63 | Wormian bones (HP:0002645) | 2.11812038 |
64 | Glomerulonephritis (HP:0000099) | 2.11784069 |
65 | Mitral stenosis (HP:0001718) | 2.09963939 |
66 | Mediastinal lymphadenopathy (HP:0100721) | 2.07504325 |
67 | Turricephaly (HP:0000262) | 2.07398998 |
68 | Broad face (HP:0000283) | 2.05938574 |
69 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.05625694 |
70 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.02810053 |
71 | Myositis (HP:0100614) | 2.01797319 |
72 | Purpura (HP:0000979) | 2.01503857 |
73 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.01029374 |
74 | Autoimmune thrombocytopenia (HP:0001973) | 2.00938002 |
75 | Esophageal varix (HP:0002040) | 1.99961781 |
76 | Cardiovascular calcification (HP:0011915) | 1.99310653 |
77 | Long toe (HP:0010511) | 1.98997142 |
78 | Spondylolisthesis (HP:0003302) | 1.98903255 |
79 | Skin nodule (HP:0200036) | 1.98841004 |
80 | Increased variability in muscle fiber diameter (HP:0003557) | 1.97683451 |
81 | Peripheral demyelination (HP:0011096) | 1.96142150 |
82 | Premature rupture of membranes (HP:0001788) | 1.95004510 |
83 | Vascular calcification (HP:0004934) | 1.94931843 |
84 | Abnormality of the common coagulation pathway (HP:0010990) | 1.94783241 |
85 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.93697762 |
86 | Natal tooth (HP:0000695) | 1.93360689 |
87 | Fragile skin (HP:0001030) | 1.93293319 |
88 | Systemic lupus erythematosus (HP:0002725) | 1.91728862 |
89 | Muscle fiber splitting (HP:0003555) | 1.90882067 |
90 | Difficulty climbing stairs (HP:0003551) | 1.89387958 |
91 | Hemorrhage of the eye (HP:0011885) | 1.88802682 |
92 | Increased connective tissue (HP:0009025) | 1.86619267 |
93 | Joint stiffness (HP:0001387) | 1.86449145 |
94 | Elbow flexion contracture (HP:0002987) | 1.85809153 |
95 | Sensorimotor neuropathy (HP:0007141) | 1.85780958 |
96 | Type 1 muscle fiber predominance (HP:0003803) | 1.84450096 |
97 | Striae distensae (HP:0001065) | 1.83793535 |
98 | Deep venous thrombosis (HP:0002625) | 1.83247961 |
99 | Aortic aneurysm (HP:0004942) | 1.82876633 |
100 | Aneurysm (HP:0002617) | 1.82122952 |
101 | Blue sclerae (HP:0000592) | 1.82119247 |
102 | Distal lower limb amyotrophy (HP:0008944) | 1.81036383 |
103 | Generalized amyotrophy (HP:0003700) | 1.80393485 |
104 | Increased CSF protein (HP:0002922) | 1.79060214 |
105 | Progressive neurologic deterioration (HP:0002344) | 1.78853867 |
106 | Ulnar bowing (HP:0003031) | 1.77660263 |
107 | Increased serum ferritin (HP:0003281) | 1.76770448 |
108 | Upper motor neuron abnormality (HP:0002127) | 1.76490733 |
109 | Episodic fever (HP:0001954) | 1.76264521 |
110 | Apathy (HP:0000741) | 1.76213787 |
111 | Mitral regurgitation (HP:0001653) | 1.75051631 |
112 | Hematochezia (HP:0002573) | 1.74760436 |
113 | Aortic dissection (HP:0002647) | 1.74519711 |
114 | Cardiomegaly (HP:0001640) | 1.73853219 |
115 | Hyperparathyroidism (HP:0000843) | 1.71517593 |
116 | Arterial thrombosis (HP:0004420) | 1.71410278 |
117 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.70853029 |
118 | Protrusio acetabuli (HP:0003179) | 1.70299268 |
119 | Back pain (HP:0003418) | 1.69867144 |
120 | Lower limb amyotrophy (HP:0007210) | 1.69064639 |
121 | Bladder diverticulum (HP:0000015) | 1.68036736 |
122 | Conjugated hyperbilirubinemia (HP:0002908) | 1.67998074 |
123 | Hyporeflexia of lower limbs (HP:0002600) | 1.67700650 |
124 | Ovoid vertebral bodies (HP:0003300) | 1.67297876 |
125 | Polycythemia (HP:0001901) | 1.67093098 |
126 | Ketoacidosis (HP:0001993) | 1.66870350 |
127 | Exercise-induced myalgia (HP:0003738) | 1.66144795 |
128 | Urticaria (HP:0001025) | 1.65605370 |
129 | Pathologic fracture (HP:0002756) | 1.64729866 |
130 | Rapidly progressive (HP:0003678) | 1.63702483 |
131 | Abnormality of the periventricular white matter (HP:0002518) | 1.63039100 |
132 | Hypoalphalipoproteinemia (HP:0003233) | 1.62800869 |
133 | EMG: myopathic abnormalities (HP:0003458) | 1.61097892 |
134 | Diminished motivation (HP:0000745) | 1.61091515 |
135 | Neuronal loss in central nervous system (HP:0002529) | 1.60587099 |
136 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.59598362 |
137 | Persistence of primary teeth (HP:0006335) | 1.59451547 |
138 | Abnormality of iron homeostasis (HP:0011031) | 1.59369491 |
139 | Scapular winging (HP:0003691) | 1.59288660 |
140 | Stroke (HP:0001297) | 1.56787716 |
141 | Exercise-induced muscle cramps (HP:0003710) | 1.55550031 |
142 | Cervical subluxation (HP:0003308) | 1.54972595 |
143 | Cerebral hemorrhage (HP:0001342) | 1.54756187 |
144 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.54669561 |
145 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.54616415 |
146 | Nephritis (HP:0000123) | 1.54546117 |
147 | Vasculitis (HP:0002633) | 1.54400941 |
148 | Dilatation of the ascending aorta (HP:0005111) | 1.54371191 |
149 | Protuberant abdomen (HP:0001538) | 1.53997235 |
150 | Retinal atrophy (HP:0001105) | 1.53988264 |
151 | * Tetraparesis (HP:0002273) | 1.52602454 |
152 | Gastrointestinal infarctions (HP:0005244) | 1.51241089 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 3.24619477 |
2 | TRIB3 | 3.20562044 |
3 | MAP3K14 | 2.60483000 |
4 | RIPK4 | 2.55430363 |
5 | NME2 | 2.51191436 |
6 | PRPF4B | 2.30608146 |
7 | KSR2 | 2.25334578 |
8 | * TBK1 | 2.22069396 |
9 | EPHB1 | 2.16050542 |
10 | IRAK3 | 2.11967809 |
11 | EPHA3 | 2.11349534 |
12 | MAP3K9 | 2.04969426 |
13 | TAOK2 | 2.03023840 |
14 | RIPK1 | 1.94413919 |
15 | MAP3K13 | 1.92362764 |
16 | ICK | 1.91139117 |
17 | BMX | 1.88332857 |
18 | SMG1 | 1.71670447 |
19 | TTN | 1.68789796 |
20 | TAOK3 | 1.65584847 |
21 | SIK1 | 1.58106889 |
22 | JAK1 | 1.56252961 |
23 | PBK | 1.54352428 |
24 | FGFR4 | 1.52909778 |
25 | PDGFRA | 1.45994989 |
26 | NTRK1 | 1.43817476 |
27 | LATS2 | 1.43501549 |
28 | MST1R | 1.43299521 |
29 | DDR2 | 1.42958929 |
30 | PTK6 | 1.41116829 |
31 | MAP3K1 | 1.40232543 |
32 | PKN2 | 1.40192157 |
33 | IKBKB | 1.37506317 |
34 | IKBKE | 1.36967102 |
35 | MAP3K2 | 1.28266417 |
36 | MAP3K11 | 1.27516435 |
37 | SCYL2 | 1.24862372 |
38 | TYK2 | 1.19076939 |
39 | CAMKK2 | 1.12371977 |
40 | PRKG2 | 1.11901185 |
41 | JAK3 | 1.10369925 |
42 | ARAF | 1.09359618 |
43 | ERBB4 | 1.08433895 |
44 | DAPK3 | 1.07807567 |
45 | TESK2 | 1.07557686 |
46 | RET | 1.07394774 |
47 | CHUK | 1.07262010 |
48 | PAK6 | 1.04104904 |
49 | CDC42BPA | 1.02846110 |
50 | FER | 1.02397024 |
51 | MYLK | 1.01200388 |
52 | JAK2 | 0.99779606 |
53 | PIM2 | 0.99213664 |
54 | ABL2 | 0.98134317 |
55 | CAMKK1 | 0.97382720 |
56 | PTK2 | 0.96826660 |
57 | PRKD2 | 0.95239193 |
58 | MET | 0.87366374 |
59 | CSK | 0.86007629 |
60 | LRRK2 | 0.85754017 |
61 | EEF2K | 0.84862381 |
62 | FGR | 0.83976321 |
63 | CDK12 | 0.82016571 |
64 | MOS | 0.81104944 |
65 | PRKD3 | 0.79020707 |
66 | CAMK1D | 0.78794610 |
67 | MTOR | 0.78340444 |
68 | MAP3K3 | 0.77939622 |
69 | IRAK4 | 0.76342423 |
70 | DAPK2 | 0.76250274 |
71 | TRPM7 | 0.76076765 |
72 | STK38 | 0.75942334 |
73 | GRK7 | 0.75164926 |
74 | MARK3 | 0.74881807 |
75 | DYRK1B | 0.73698010 |
76 | IRAK2 | 0.72062524 |
77 | PAK3 | 0.71578451 |
78 | ALK | 0.70749342 |
79 | PDPK1 | 0.69580022 |
80 | PRKCH | 0.67856748 |
81 | MATK | 0.67294403 |
82 | PDGFRB | 0.67132718 |
83 | MAP2K1 | 0.65363993 |
84 | TAOK1 | 0.65328575 |
85 | PAK2 | 0.65223148 |
86 | EPHB2 | 0.63917520 |
87 | RPS6KA2 | 0.62961196 |
88 | IRAK1 | 0.62916966 |
89 | SIK3 | 0.61604030 |
90 | MAP3K5 | 0.61125015 |
91 | GSK3A | 0.60749326 |
92 | CAMK2G | 0.59392218 |
93 | HCK | 0.59064902 |
94 | MAPK15 | 0.58942052 |
95 | SIK2 | 0.57096676 |
96 | MARK2 | 0.54746633 |
97 | ZAP70 | 0.53861554 |
98 | MAP3K10 | 0.53850828 |
99 | WNK4 | 0.53794241 |
100 | NEK9 | 0.52982258 |
101 | MAP3K8 | 0.52664695 |
102 | EPHA2 | 0.52385284 |
103 | TESK1 | 0.51850390 |
104 | DMPK | 0.51703996 |
105 | FGFR3 | 0.51448903 |
106 | MAPK11 | 0.51344981 |
107 | EGFR | 0.50621730 |
108 | HIPK2 | 0.48683924 |
109 | CDK6 | 0.47793934 |
110 | BRAF | 0.47760835 |
111 | BLK | 0.47019546 |
112 | MAPKAPK3 | 0.46986525 |
113 | FES | 0.46933946 |
114 | KIT | 0.45840070 |
115 | LMTK2 | 0.45789131 |
116 | KSR1 | 0.45660398 |
117 | MAP2K3 | 0.45222247 |
118 | TYRO3 | 0.45128390 |
119 | ILK | 0.44632946 |
120 | TGFBR2 | 0.44203192 |
121 | PAK4 | 0.43812631 |
122 | PDK2 | 0.42798446 |
123 | CDK9 | 0.42586332 |
124 | LIMK1 | 0.42332975 |
125 | PHKG1 | 0.42204861 |
126 | PHKG2 | 0.42204861 |
127 | MAPKAPK2 | 0.40217461 |
128 | PDK1 | 0.39717331 |
129 | CAMK1G | 0.39314439 |
130 | PRKCZ | 0.38739238 |
131 | ROCK2 | 0.35751807 |
132 | RPS6KL1 | 0.35603643 |
133 | RPS6KC1 | 0.35603643 |
134 | MAPK12 | 0.34773482 |
135 | MAP3K6 | 0.33667347 |
136 | MAPK4 | 0.33292198 |
137 | STK10 | 0.33287220 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.76035667 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.18275529 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.05977622 |
4 | Lysosome_Homo sapiens_hsa04142 | 2.04332889 |
5 | Galactose metabolism_Homo sapiens_hsa00052 | 1.72085973 |
6 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.63278149 |
7 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.60032689 |
8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.59819189 |
9 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.59597908 |
10 | Legionellosis_Homo sapiens_hsa05134 | 1.59054343 |
11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.56978993 |
12 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.53106215 |
13 | Malaria_Homo sapiens_hsa05144 | 1.50847866 |
14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.50775702 |
15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.49801820 |
16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45888593 |
17 | Tuberculosis_Homo sapiens_hsa05152 | 1.40331159 |
18 | Phagosome_Homo sapiens_hsa04145 | 1.38767680 |
19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.38297555 |
20 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.33831134 |
21 | Pertussis_Homo sapiens_hsa05133 | 1.33493652 |
22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.31052142 |
23 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.26279461 |
24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.22232002 |
25 | Salmonella infection_Homo sapiens_hsa05132 | 1.21754271 |
26 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.21541174 |
27 | Prion diseases_Homo sapiens_hsa05020 | 1.20963790 |
28 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.18255831 |
29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.17852227 |
30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.16316618 |
31 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.15323432 |
32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.07912085 |
33 | Amoebiasis_Homo sapiens_hsa05146 | 1.07825147 |
34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.07300486 |
35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.06788681 |
36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06441188 |
37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.05929380 |
38 | Shigellosis_Homo sapiens_hsa05131 | 1.03124743 |
39 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.01974488 |
40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.00831207 |
41 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00673435 |
42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.00007906 |
43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98890361 |
44 | Insulin resistance_Homo sapiens_hsa04931 | 0.98791992 |
45 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.96220003 |
46 | Apoptosis_Homo sapiens_hsa04210 | 0.96117464 |
47 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.95908628 |
48 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95569205 |
49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92966390 |
50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.89479995 |
51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88028314 |
52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87929536 |
53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86446368 |
54 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.82481236 |
55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.81559696 |
56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.81196053 |
57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78842667 |
58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.78456254 |
59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78355468 |
60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77385159 |
61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76054351 |
62 | Influenza A_Homo sapiens_hsa05164 | 0.75145214 |
63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74109339 |
64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.73822037 |
65 | Allograft rejection_Homo sapiens_hsa05330 | 0.73747872 |
66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72897247 |
67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72506414 |
68 | Endocytosis_Homo sapiens_hsa04144 | 0.72491863 |
69 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.72047811 |
70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71447079 |
71 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71164981 |
72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.70699836 |
73 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.69467123 |
74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68881179 |
75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.68744119 |
76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67346897 |
77 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67190864 |
78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66561414 |
79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66169454 |
80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.65832665 |
81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64313770 |
82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64018321 |
83 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62781877 |
84 | Measles_Homo sapiens_hsa05162 | 0.62309250 |
85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.62017926 |
86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.61657742 |
87 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60394109 |
88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60105135 |
89 | Glioma_Homo sapiens_hsa05214 | 0.59206722 |
90 | Hepatitis C_Homo sapiens_hsa05160 | 0.59182396 |
91 | Asthma_Homo sapiens_hsa05310 | 0.58918763 |
92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58366842 |
93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57965243 |
94 | Bladder cancer_Homo sapiens_hsa05219 | 0.57863691 |
95 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57403088 |
96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57379846 |
97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57379073 |
98 | Bile secretion_Homo sapiens_hsa04976 | 0.56473495 |
99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55903883 |
100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55676109 |
101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55237351 |
102 | Focal adhesion_Homo sapiens_hsa04510 | 0.55207988 |
103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55187284 |
104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54028681 |
105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53841856 |
106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52552667 |
107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51543097 |
108 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.50635135 |
109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50600475 |
110 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50147675 |
111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50074947 |
112 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.49701306 |
113 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47957427 |
114 | Mineral absorption_Homo sapiens_hsa04978 | 0.47515964 |
115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.46146013 |
116 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.45779948 |
117 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.45558436 |
118 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.44890052 |
119 | Hepatitis B_Homo sapiens_hsa05161 | 0.44703041 |
120 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44321606 |
121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43340823 |
122 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43231467 |
123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42478741 |
124 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.42413634 |
125 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42105948 |
126 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42011824 |
127 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41561043 |
128 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.41475710 |
129 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.40759805 |
130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39351775 |
131 | Platelet activation_Homo sapiens_hsa04611 | 0.38974448 |
132 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38805058 |
133 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36797357 |